Sahijoan, Dayang S.
HRN: 07-47-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2023
LEVOFLOXACIN 500MG (TAB)
05/06/2023
05/12/2023
ORAL
500mg
OD
Interstitial Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes